Clover Health Investments...

NASDAQ: CLOV · Real-Time Price · USD
2.64
0.07 (2.72%)
At close: Aug 15, 2025, 3:59 PM
2.69
1.89%
After-hours: Aug 15, 2025, 06:13 PM EDT

Clover Health Investments Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
477.62M 462.33M 336.96M 330.99M 356.26M 346.92M 510.25M 306.03M 320.14M 321.99M 898.79M 856.82M 846.7M 874.38M 432.04M 427.16M 412.47M 200.32M
Cost of Revenue
377.99M 353.44M 243.04M 249.77M 248.35M 265.16M 447.99M 235.78M 244.26M 274.79M 893.64M 839.8M 858.79M 861.72M 441.8M 436.32M 458.5M 214.42M
Gross Profit
99.63M 108.89M 93.92M 81.21M 107.91M 81.76M 62.27M 70.24M 75.88M 47.2M 5.15M 17.02M -12.09M 12.66M -9.77M -9.16M -46.03M -14.1M
Operating Income
-10.56M -1.27M -21.45M -8.79M 7.19M -22.7M -65.66M -33.62M -28.88M -79.7M -107.16M -74.1M -102.73M -87.48M -186.79M -149.25M -181.86M -119.09M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-10.58M -1.27M -21.48M -8.79M 7.17M -23.17M -70.47M -33.62M -28.89M -79.7M -84.05M -75.49M -104.36M -75.49M -187.2M -34.53M -317.61M -48.42M
Net Income
-10.58M -1.27M -22.09M -9.15M 7.41M -19.17M -70.47M -41.47M -28.81M -72.61M -84.05M -75.49M -104.36M -75.49M -187.2M -34.53M -317.61M -48.42M
Selling & General & Admin
109.79M 109.7M 115.02M 90.2M 99.92M 103.79M 109.93M 101.6M 104.15M 126.63M 124.35M 117.97M 117.53M 126.79M 114.21M 119.21M 107.81M 104.64M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
394K 466K 344K -199K 803K 671K 18M 2.26M 611K 276K -12.04M -26.86M -26.89M -26.65M 62.81M 20.88M 28.02M 351K
Operating Expenses
110.19M 110.16M 115.37M 90M 100.73M 104.46M 127.93M 103.86M 104.76M 126.9M 112.31M 91.11M 90.64M 100.14M 177.02M 140.09M 135.83M 104.99M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a 7K n/a 139K 413K 408K 403K 412K 426K 1.24M 14.84M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
488.18M 463.61M 358.41M 339.77M 349.07M 369.63M 575.91M 339.64M 349.02M 401.69M 1.01B 930.91M 949.43M 961.86M 618.83M 576.42M 594.33M 319.41M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
508.89M 497.06M 491.87M 490.18M 487.48M 486.37M 481.61M 480.77M 479.16M 478.81M 477.9M 477.69M 476.06M 473.03M 470.85M 420.63M 408.31M 376.17M
Shares Outstanding (Diluted)
508.89M 497.06M 491.87M 490.18M 495.18M 567.45M 481.61M 480.77M 479.16M 478.81M 477.9M 477.69M 476.06M 473.03M 470.85M 420.63M 408.31M 376.17M
EPS (Basic)
-0.02 -0.00 -0.04 -0.02 0.01 -0.04 -0.15 -0.09 -0.06 -0.15 -0.18 -0.16 -0.22 -0.16 -0.4 -0.08 -0.78 -0.13
EPS (Diluted)
-0.02 -0.00 -0.04 -0.02 0.01 -0.04 -0.15 -0.09 -0.06 -0.15 -0.18 -0.16 -0.22 -0.16 -0.4 -0.08 -0.78 -0.13
EBITDA
-10.18M -808K -21.14M -8.45M 7.5M -22.03M -69.8M -33.06M -27.88M -77.61M -84.75M -74.46M -103.37M -74.26M -185.94M -33.98M -316.26M -33.42M
EBIT
-10.58M -1.27M -21.48M -8.79M 7.17M -22.35M -70.47M -33.62M -28.88M -77.89M -83.91M -75.08M -103.95M -75.09M -186.79M -34.1M -316.37M -33.58M
Depreciation & Amortization
394K 466K 344K 339K 330K 318K 674K 557K 999K 279K -841K 616K 586K 826K 848K 120K 118K 160K